Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation

Mantle cell lymphoma (MCL) is a type of non-Hodgkins lymphoma (NHL) associated with poor progression-free and overall survival. There is a high relapse rate with conventional cytotoxic chemotherapy. Intensive combination chemotherapy including rituximab, dose intense CHOP- (cyclophosphamide-doxorubi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanbhag, Satish, Smith, Mitchell R, Emmons, Robert VB
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781733/
https://www.ncbi.nlm.nih.gov/pubmed/24198514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781733/
https://www.ncbi.nlm.nih.gov/pubmed/24198514

Ejemplares similares